Basharat Ali | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Basharat Ali | Drug Discovery and Development | Pakistan

University of Baltistan | Pakistan

Assist. Prof. Dr. Basharat Ali is a distinguished researcher and academician specializing in medicinal chemistry, heterocyclic synthesis, and polymer science with extensive expertise in designing and synthesizing biologically active compounds. Currently serving as an Assistant Professor in the Department of Chemistry at the University of Baltistan, Skardu, Pakistan, he has a diverse academic and research background, including postdoctoral research at the College of Pharmaceutical Science, Soochow University, China, where he contributed to the development of chemiluminescent dioxetane probes for disease diagnosis, fluorescent probes for hydrogen sulfide detection, and anthraquinone derivatives as anti-infective agents. He has also worked as a research assistant at Zhejiang University, China, focusing on mechanistic studies of olefin polymerization using α-Diimine nickel(II) catalysts, and at the HEJ Research Institute of Chemistry, University of Karachi, where he specialized in synthetic organic chemistry and bioactive heterocycles.Dr. Basharat Ali’s research interests include the synthesis, structural modification, and biological evaluation of medicinally important synthetic derivatives, probe design for environmental and biomedical applications, multicomponent reactions, polymer synthesis, and catalytic system development. He has supervised numerous postgraduate students and contributed extensively to the field with multiple high-impact publications in reputable international journals. Some of his significant research publications include Synthesis and biological evaluations of 1,3,4-thiadiazole derivatives as dual acting enzyme inhibitors to target inflammation and diabetes, Carbothioamides as anticancer agents: synthesis, in-vitro activity, structure-activity relationship evaluations and molecular docking, Synthesis of (E)-3-(aryl)-1-phenylprop-2-en-1-one Chalcone Derivatives for Hyperglycemic Effect in Diabetes.

Profile: Google Scholar

Featured Publications

Li, S., Zhan, L., Zhao, W., Zhang, S., Ali, B., Fu, Z., Lau, T. K., Lu, X., Shi, M., Li, C. Z., … (2018). Revealing the effects of molecular packing on the performances of polymer solar cells based on A–D–C–D–A type non-fullerene acceptors. Journal of Materials Chemistry A, 6(25), 12132–12141.

Ali, F., Khan, K. M., Salar, U., Iqbal, S., Taha, M., Ismail, N. H., Perveen, S., … (2016). Dihydropyrimidones: As novel class of β-glucuronidase inhibitors. Bioorganic & Medicinal Chemistry, 24(16), 3624–3635.

Abbas, A., Ali, B., Khan, K. M., Iqbal, J., Rahman, S. U., Zaib, S., Perveen, S. (2019). Synthesis and in vitro urease inhibitory activity of benzohydrazide derivatives, in silico and kinetic studies. Bioorganic Chemistry, 82, 163–177.

Ali, B., Khan, K. M., Hussain, S., Hussain, S., Ashraf, M., Riaz, M., Wadood, A., … (2018). Synthetic nicotinic/isonicotinic thiosemicarbazides: In vitro urease inhibitory activities and molecular docking studies. Bioorganic Chemistry, 79, 34–45.

Naz, F., Latif, M., Salar, U., Khan, K. M., Al-Rashida, M., Ali, I., Ali, B., Taha, M., … (2020). 4-Oxycoumarinyl linked acetohydrazide Schiff bases as potent urease inhibitors. Bioorganic Chemistry, 105, 104365.

Salar, U., Khan, K. M., Taha, M., Ismail, N. H., Ali, B., Perveen, S., Ghufran, M., … (2017). Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl aryl carboxylate derivatives. European Journal of Medicinal Chemistry, 125, 1289–1299.

Ali, M., Khan, K. M., Salar, U., Ashraf, M., Taha, M., Wadood, A., Hamid, S., Riaz, M., … (2018). Synthesis, in vitro α-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives. Molecular Diversity, 22(4), 841–861.

Ahmad Saeed | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Mr. Ahmad Saeed | Drug Delivery Systems | Best Researcher Award

University of Education Lahore | Pakistan

Mr. Ahmad Saeed is a dedicated researcher in the field of analytical chemistry with a strong academic and research background. Currently pursuing a Bachelor of Science in Chemistry at the University of Education, Township Campus, Lahore, he has consistently demonstrated academic excellence with a notable CGPA of 3.60. Throughout his academic journey, he has actively participated in multiple research projects, including the development of biodegradable films containing biological macromolecules impregnated with curcumin for food preservation, investigation of the toxic effects of heavy metals in cosmetics on human health, and the advancement of revolutionized electrochemical sensors utilizing 2D materials as sensor electrodes. He has also contributed to innovative environmental projects, such as Clay Eco Filters, aimed at developing metal nanoparticle-impregnated clay tablets for water purification, and Ecofoil, focused on synthesizing biodegradable films for sustainable food packaging solutions.Mr. Ahmad Saeed has enriched his academic experience through hands-on laboratory work as a Graduate Research Assistant, where he worked extensively on projects involving the synthesis of nanomaterials for environmental and analytical applications. As a Teaching Assistant, he contributed to the academic development of students by assisting in atomic spectrophotometry courses, grading assignments, and providing academic guidance. He has participated in major conferences, including the International Conference on Trends and Research in Chemistry and the International Conference on Material Chemistry and Industrial Technologies, serving as both an organizer and a participant, thus gaining exposure to scholarly dialogues and academic networking.His research contributions are reflected in several scholarly publications, including Multivariate Statistical Analysis of Cosmetics Due to Potentially Toxic/Heavy Metal(loid) Contamination: Source Identification for Sustainability and Human Health Risk Assessment published in Sustainability, Structural Development of Curcumin: A Natural Product Arsenal for Diverse Therapeutic Targets – Seizing Opportunities Through Serendipity and Rational Design in the Journal of Molecular Structure, and FDA-Approved Sulfonamides-Containing Molecules: An Insightful Review on the Synthesis Strategy, Medical Indication, and Their Binding Mode under review in Chemistry and Biodiversity. These works highlight his interest in environmental sustainability, analytical chemistry, natural products, and biomedical applications.

Profile: Orcid

Featured Publications

Ahmed, M., Basheer, S., Mughram, M. H. A., Iqbal, D. N., Qamar, S., Saeed, A., Batool, R., Sanaullah, M., Raza, H., & Hussain, R. (2025). Structural development of curcumin: A natural product arsenal for diverse therapeutic targets—Seizing opportunities through serendipity and rational design. Journal of Molecular Structure.

Aslam, A. A., Ahmed, M., Mughram, M. H. A. L., Habib-ur-Rahman Mahmood, M., Basheer, S., Hussain, R., Eiman, E., Sanaullah, M., Raza, H., Saeed, A., et al. (2025). Sulfonamides as a promising scaffold in drug discovery: An insightful review on FDA-approved molecules, synthesis strategy, medical indication, and their binding mode. Chemistry and Biodiversity.

Ahmed, M., Basheer, S., Mughram, M. H. A., Iqbal, D. N., Qamar, S., Saeed, A., Batool, R., Sanaullah, M., Raza, H., & Hussain, R. (2025). Multivariate statistical analysis of cosmetics due to potentially toxic/heavy metal(loid) contamination: Source identification for sustainability and human health risk assessment. Sustainability.

Alptug Atila | Pharmaceutical Analysis | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Alptug Atila | Pharmaceutical Analysis | Best Researcher Award

Ataturk University | Turkey

Prof. Alptug Atila is a distinguished scholar in the field of analytical chemistry with a robust academic foundation built at Ataturk University, where he pursued undergraduate studies in chemistry, followed by postgraduate and doctoral research specializing in analytical chemistry. Over the years, he has attained profound expertise across diverse research areas, including atomic mass spectrometry, atomic and molecular spectroscopy, bioanalytical methods, pharmaceutical analysis, chromatographic analysis, molecular mass spectroscopy, and separation techniques. His work also spans natural sciences, electromagnetic methods, sample preparation, and spectroscopical methods, reflecting an interdisciplinary approach to solving complex analytical challenges.Currently serving as a professor in the Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences at Ataturk University, Prof. Atila has made significant contributions to academia and research. His administrative roles, such as Assistant Manager of Research and Application Center, further underscore his leadership in promoting innovative research and laboratory practices. Equipped with certifications in Quality Management and Good Laboratory Practice (GLP) from the Turkish Accreditation Agency (TÜRKAK), he combines technical excellence with rigorous quality standards.Prof. Atila’s prolific research output is evident in his extensive list of publications across prestigious journals indexed in SCI, SSCI, and AHCI. Some of his remarkable works include Analyzing Quinoa Seeds: LC–MS/MS and GC–MS/MS Approaches for Identifying a Nutrient-Rich Functional Food in Alzheimer’s and Diabetes Care, A Comparative Evaluation of Salivary and Plasma Bisphenol-A Levels in Patients Released from Four Different Orthodontic Appliances: Ultra-Performance Liquid Chromatography-Mass Spectrometry Study, and Comprehensive Analysis of Elemental and Metabolite Composition in Boraginaceae Species from Türkiye. He has also advanced pharmaceutical analytics through studies such as Method Development and Validation for Determination of N-Nitrosamines in Pharmaceutical Preparations by LC-MS/MS: Application to Extractables and Leachables Studies and Changes of Plasma Amino Acid Levels and Metabolic Pathways in Isotretinoin Therapy: Insights into Managing Acne Vulgaris Side Effects.

Profile: Scopus

Featured Publications

Atila A., Akman T. Ç., Yazıcı M.
Changes of plasma amino acid levels and metabolic pathways in isotretinoin therapy: insights into managing acne vulgaris side effects. Archives of Dermatological Research. Citations: 0

Atila A., Öner S., Kadı A., Tekman E., Kararenka C., Özer E. B., Ergin K. N., Yuca H., Arslan M. E., Duman R., Acarşahin A., et al.
Morphological, anatomical, and bioactive properties of Hypericum scabrum L.: effects on diabetes mellitus, Alzheimer’s disease, and HDFa fibroblasts and U87-MG cancer cells. Protoplasma. Citations: 2

Atila A., Halici H., Un H., Celik S., Karakoy Z., Bayraktutan Z., Ozlu C., Cadirci E., Halici Z., Mercantepe F.
Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia Cells. Protein Journal. Citations: 0

Atila A., Coban F., Yuca H., Aydin B., Tosun M., Yazıcı A., Karakaya S., Tan M., Ozer H.
Analyzing Quinoa Seeds: LC–MS/MS and GC–MS/MS Approaches for Identifying a Nutrient-Rich Functional Food in Alzheimer’s and Diabetes Care. Chemistry and Biodiversity. Citations: 0

Shangqing Gong | Vaccine Development |

Published on by Top Pharmaceutical

Mr. Shangqing Gong | Vaccine Development | Best Researcher Award

University of South China | China

Mr. Shangqing Gong is a highly prolific researcher affiliated with East China University of Science and Technology, specializing in quantum optics, optical non-reciprocity, optomechanics, and nonlinear light–matter interaction. His publication record includes over two hundred scientific works, with a citation count exceeding several thousand, and a strong h-index indicating his influence in the field. He has been involved in multiple collaborative research projects across institutions, contributing both theoretical and experimental advances, particularly in cavity quantum electrodynamics, electromagnetically induced transparency, and opto-electromechanical hybrid systems.Gong’s contributions extend to designing schemes for nonreciprocal cavities using chiral broadening, demonstrating isolation contrasts between clockwise and counter-clockwise cavity modes, and exploring the nonreciprocal transmission of vortex beams via Raman transitions. He has worked on enhancing cross-Kerr nonlinearities through mechanical parametric amplification, applying these to photon blockade effects and optomechanical electrometers. His research also involves electrical control of nonlinear optical phenomena in hybrid systems, coupling optical and mechanical modes with adjustable interactions, as well as theoretical proposals for phase-controllable four-wave mixing between microwave and optical domains. Mr. Gong collaborates with co-authors from multiple universities, contributes to international journals, and engages in multi-disciplinary work spanning physics, optics, and materials science.His professional memberships include participation in scientific societies related to optics and photonics; he also serves peer reviewer or contributor roles in journals and conferences in quantum optics and photonics. His areas of research encompass optical isolation devices, non-linear optics, optomechanical coupling, quantum information processing, light-matter coupling, and photon-phonon interaction. Through his work, Gong has advanced understanding of how nonlinear optical effects can be engineered, controlled, and applied in devices for photonic communication, sensing, and quantum technologies.

Profile: Google Scholar

Featured Publications

Gong, S., Zhang, M., Dai, J., & Jiang, Y. (2025). Dynamic analysis and optimal control of fractional-order time-delayed SIR models with medical observation and Hattaf-Yousfi functional responses. Results in Engineering, 107209.

Gong, S., Zhang, M., Dai, J., & Jiang, Y. (2025). Dynamic optimal control of an SEIQRS epidemic model on complex network. [Journal Name, Volume(Issue), pages if available].

Guangda Li | Pharmacogenomics | Best Researcher Award

Published on by Top Pharmaceutical

Mr. Guangda Li | Pharmacogenomics | Best Researcher Award

Fourth Military Medical University | China

Mr. Guangda Li is an accomplished researcher with a strong concentration in materials science, nanocomposites, and electrochemical energy systems. He holds advanced academic credentials, including work in areas of battery electrodes, bioactive bone cement, and magnetic-material-based therapeutics. Over the course of his career, he has published more than fifty research works, which have been cited over eight hundred times in scientific databases. His research includes development of injectable magnetic composite ceramics for self-regulating hyperthermia in bone tumor treatment, design of antimicrobial bone cements, and fabrication of hollow-structured cathode materials with high capacity and cycling stability for zinc-ion batteries. He has also participated in patenting processes related to bone cement and bioactive glass ceramics, and actively collaborates with co-researchers from multiple institutions for joint publications. His editorial roles and conference peer-review contributions further reflect his engagement with the scientific community. His professional memberships and affiliations span institutions focused on materials engineering, biomedical materials, and chemistry, reflecting his interdisciplinary research interest in biomaterials, hyperthermia therapy, electrocatalysis, and wound healing.

Profile: Orcid

Featured Publications

Author(s). (2025). Rapid and ultrasensitive detection of Staphylococcus aureus by a one-pot system integrating Pyrococcus furiosus Argonaute with loop-mediated isothermal amplification. Journal of Microbiology and Biotechnology. Advance online publication.

Allison Hilberer | Dermatological Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Allison Hilberer | Dermatological Pharmacology | Best Researcher Award

Institute for In Vitro Sciences | United States

Mrs. Allison Hilberer is a distinguished toxicologist with a robust academic foundation and extensive expertise in in vitro toxicology, phototoxicity, and ocular and dermal safety assessments. She holds a Graduate Certificate in Clinical Toxicology from the University of Florida College of Pharmacy, a Master of Science in Biology from George Mason University, a Bachelor of Arts in Biology from Keuka College, and an Associate in Science in Liberal Arts and Sciences from Finger Lakes Community College. Additionally, she completed advanced toxicology training at the Mid-America Toxicology Course, further strengthening her scientific and regulatory proficiency in toxicological methods. As a Diplomate of the American Board of Toxicology (DABT), she maintains high standards of professional competency and scientific rigor in her work.Mrs. Hilberer has built an exceptional career at the Institute for In Vitro Sciences, Inc. (IIVS), advancing from early roles as Biologist and Laboratory Supervisor to her current position as Senior Toxicologist, Study Director, and Program Leader, overseeing BCOP, Photosafety, and 96-well assays. Her leadership has extended to training biologists, coordinating complex toxicological studies, refining in vitro methodologies, and ensuring adherence to Good Laboratory Practices (GLPs). Throughout her career, she has successfully directed assays addressing phototoxicity, ocular and dermal irritation, photoallergy, and sensitization risks while implementing cutting-edge technologies to advance alternative testing strategies. She has represented the International Council on Animal Protection in OECD Programmes (ICAPO) for eye, skin, and phototoxicity assays, contributing to global scientific and regulatory dialogues on reducing animal testing through validated alternative methods.

Profile: Orcid

Featured Publications

Hilberer, A., Hoffman, L., Madrid, M., Labib, R., & Costin, G.-E. (2025). Assessment of phototoxicity potential of botanicals as cosmetic ingredients using the in vitro 3T3 neutral red uptake phototoxicity test. Regulatory Toxicology and Pharmacology. Advance online publication.

Keebaugh, A. J., Steele, M. L., Islas-Robles, A., Phillips, J., Hilberer, A., Cantrell, K., Chushak, Y. G., Mattie, D. R., Clewell, R. A., & Merrill, E. A. (2025). Development of preliminary candidate surface guidelines for Air Force-relevant dermal sensitizers using new approach methodologies. Toxics, 13(8), 660. https://doi.org/10.3390/toxics13080660

Ruparel, N., Islas-Robles, A., Hilberer, A., Cantrell, K., Madrid, M., Ryan, C., Gerberick, G. F., & Persaud, R. (2024). Deriving a point of departure for assessing the skin sensitization risk of wearable device constituents with in vitro methods. Food and Chemical Toxicology, 114, 725. https://doi.org/10.1016/j.fct.2024.114725

Use of alternative test methods in a tiered testing approach to address photoirritation potential of fragrance materials.

Jun Liu | Pharmaceutical Manufacturing | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jun Liu | Pharmaceutical Manufacturing | Best Researcher Award

Nanchang University | China

Dr. Jun Liu is a distinguished scholar specializing in Forest Products Chemical Processing Engineering, having earned his Ph.D. from Beijing Forestry University. Following his doctoral studies, he pursued advanced postdoctoral research in Power Engineering and Engineering Thermophysics at the Institute of Engineering Thermophysics, Chinese Academy of Sciences. Currently, he serves as the Deputy Director and Secretary of the Party Branch in the Department of Process Equipment and Control Engineering at the School of Resources and Environment, Nanchang University, where he has become an influential figure driving research and academic innovation.A prolific contributor to scientific literature, Dr. Liu has authored and co-authored several influential publications in high-impact journals. Some of his notable works include AHP-Optimized Processing Technology and Quality Evaluation System for Rehmanniae Radix published in LWT-Food Science and Technology, Analysis of the Microscopic Interactions Between Processed Polygonatum Cyrtonema Polysaccharides and Water featured in the Journal of Molecular Graphics and Modelling, and Development and Application of the New Integrated Equipment and Process of the Nine-Steam-Nine-Bask Method in the Processing of Polygonatum Cyrtonema published in Processes.Dr. Liu’s research spans a wide spectrum of topics, including the study of chemical components in traditional Chinese medicine, quality control and standardization, resource utilization, computer simulation, intelligent manufacturing, and related interdisciplinary areas. He has successfully led and contributed to numerous national and provincial research projects focusing on innovative processing technologies for medicinal plants, solar-assisted heat pump drying systems, and integrated cultivation and processing technologies for medicinal resources. His efforts have advanced both theoretical knowledge and practical applications in chemical processing engineering, particularly in the field of traditional Chinese medicine and sustainable resource utilization.

Profile: Orcid

Featured Publications

Hu, X., Hu, Z., Tu, W., Huang, Z., Pan, Q., Liu, J., & Deng, T. (2025). AHP-optimized processing technology and quality evaluation system for Rehmanniae Radix. LWT.

Liu, J., Chen, C., Tu, W., Liu, W., & Zhang, Y. (2023). Analysis of the microscopic interactions between processed Polygonatum cyrtonema polysaccharides and water. Journal of Molecular Graphics and Modelling.

Liu, J., Zhang, Z., Huai, X., Wei, Y., Zhu, J., Li, X., Xu, P., & Ijabadeniyi, O. A. (2022). Development and application of the new integrated equipment and process of the Nine-Steam-Nine-Bask method in the processing of Polygonatum cyrtonema. Processes.

Liu, J. (2019). Preparation of double-layered structural materials with partially reduced graphene oxide and their application in the photothermal evaporation process. Science of Advanced Materials.

Liu, J. (n.d.). Molecular structure and spectral characteristics of hyperoside and analysis of its molecular imprinting adsorption properties based on density functional theory.

Sofia Gronskaia | Endocrine Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Sofia Gronskaia | Endocrine Pharmacology | Best Researcher Award

The National Medical Research Center for Endocrinology | Russia

Mrs. Sofia Gronskaia is a highly accomplished medical professional and researcher specializing in endocrinology, molecular genetics, and rare endocrine disorders. She completed her MD with honors from Sechenov University, followed by a residency in endocrinology at the National Medical Research Center for Endocrinology. She further earned a Ph.D. in endocrinology with a thesis focused on FGF-23-secreting tumors, reflecting her dedication to advancing knowledge in rare endocrine and skeletal disorders. Currently, she is pursuing a residency in genetics at the Research Center for Medical Genetics, combining clinical expertise with cutting-edge genomic research to unravel complex endocrine pathologies.Mrs. Gronskaia has undertaken extensive training in dietetics, molecular biology, genetics, and next-generation sequencing data analysis at prestigious institutions, including the Moscow Institute of Physics and Technology and the Research Center for Medical Genetics. Professionally, she has contributed as a Junior Research Fellow in Molecular Oncoendocrinology and currently serves as an endocrinologist at the National Medical Research Center for Endocrinology. Her research endeavors are extensive, serving as Principal Investigator on the RSF Grant for integrating genomic and transcriptomic data to improve early diagnosis and therapeutic target identification in endocrine tumors with paraneoplastic syndrome. She has also contributed to state assignments on developing personalized diagnostic approaches for osteoporosis secondary to endocrinopathies and exploring novel technologies for rare skeletal diseases.Her pioneering work is reflected in publications across leading journals. Notable works include A registry for patients with chronic hypoparathyroidism in Russian adults in Endocrine Connections, Denosumab for osteoporosis in patients with primary hyperparathyroidism and mild-to-moderate renal insufficiency in Endocrine, and Bone Health ECHO Case Report: Rare cases of hypophosphatemia and low-traumatic fractures in patients with type 1 diabetes mellitus in the Journal of Clinical Densitometry.

Profile: Orcid

Featured Publications

Gronskaia, S. A., Belaya, Z. E., Rozhinskaya, L. Y., Melnichenko, G. A., Dubovitskaya, T. A., Mamedova, E. O., Rodionova, S. S., Buklemishev, Y. V., Pigarova, E. A., & Degtyarev, M. V. (2023). Clinical features, diagnostics and treatment of FGF23 secreting tumors: Series of 40 clinical cases. Problems of Endocrinology.

Gronskaia, S. A., Golounina, O. O., Buklemishev, Y. V., Khairieva, A. V., Degtyarev, M. V., Rozhinskaya, L. Y., & Belaya, Z. E. (2023). A clinical case of phosphopenic osteomalacia due to paraneoplastic secretion of metastatic prostate cancer. Osteoporosis and Bone Diseases.

Gronskaia, S., Belaya, Z., Rozhinskaya, L., Mamedova, E., Vorontsova, M., Solodovnikov, A., Golounina, O., & Melnichenko, G. (2022). Denosumab for osteoporosis in patients with primary hyperparathyroidism and renal insufficiency. ResearchSquare.

Gronskaia, S. A., Belaya, Z. E., & Melnichenko, G. A. (2022). FGF23 tumor-induced osteomalacia, ФРФ23-индуцированная остеомаляция опухолевого генеза. Problemy Endokrinologii.

Golounina, O. O., Pavlova, M. G., Gronskaia, S. A., Kaznacheeva, T. V., Dzeranova, L. K., Belaya, J. E., & Fadeev, V. V. (2021). Cushing’s syndrome and pregnancy: Diagnostic, treatment and management tactics. Russian Bulletin of Obstetrician-Gynecologist.

Gronskaia, S. A., Belaya, Z. E., Rozhinskaya, L. Y., Melnichenko, G. A., & others. (n.d.). A registry for patients with chronic hypoparathyroidism in Russian adults. Endocrine Connections. [Full citation details needed for DOI]

Di Yang | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Di Yang | Cardiovascular Pharmacology | Best Researcher Award

Fudan University | China

Assoc. Prof. Dr. Di Yang is a distinguished researcher in the field of cardiovascular pharmacology with an academic journey beginning at Harbin Medical University, where he completed both his B.S. and M.S. degrees in Pharmacy and Pharmacology, respectively, followed by a Ph.D. in Cardiovascular Pharmacology from the School of Pharmacy, Fudan University. Currently serving as an Associate Professor at the Human Phenome Institute, Fudan University, Dr. Yang has developed a remarkable research career with postdoctoral training at Fudan University’s Basic Medical Sciences and an extensive record of competitive research grants, including multiple projects funded by the National Natural Science Foundation of China and the Shanghai Municipal Science and Technology Commission. His innovative work spans vascular biology, cardiovascular aging, epigenetics, and metabolic disorders, focusing on critical mechanisms involving pyruvate dehydrogenase kinase 4, histone methyltransferases SMYD2 and SMYD3, and m6A demethylase ALKBH5 in vascular remodeling, endothelial aging, and cardiac hypertrophy. As a prolific author, Dr. Yang has contributed significantly to high-impact journals with key publications such as The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy, Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α-sXBP1-GATA4 pathway, Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity, Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation, H3K4 methyltransferase Smyd3 mediates vascular smooth muscle cell proliferation, migration and neointima formation, The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis, Histone methyltransferase Smyd3 is a new regulator for vascular senescence.

Profile: Orcid

Featured Publications

Chen, M., & Yang, D. (2025). Current insights into obesity and m6A modification. Biomedicines, 13(9), 2164.

Chen, M., Su, H., Shu, M., Shen, F., Lu, Y., Wu, S., Su, Z., Yu, M., & Yang, D. (2024). The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. Cell Death & Disease, 15, 285.

Su, H., Xu, J., Su, Z., Xiao, C., Wang, J., Zhong, W., Meng, C., Yang, D., & Zhu, Y. (2023). Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α–sXBP1–GATA4 pathway. Cellular and Molecular Life Sciences, 80, 159.

Su, H., Meng, C., Xu, J., Su, Z., Xiao, C., & Yang, D. (2022). Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation. Cell Death & Disease, 13, 899.

Jinyu Liu | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Jinyu Liu | Drug Discovery and Development | Best Researcher Award

School of Public Health Jilin University | China

Mr. Jinyu Liu is a distinguished scholar in the fields of stem cell biology, regenerative medicine, toxicology, tissue engineering, and tumor pathobiology. He began his academic journey at the N. Bethune University of Medical Sciences, where he successfully completed his MD, followed by a Master’s degree in Toxicology and a Ph.D. in Biochemistry at the Institute of Regenerative Medicine. Building on this strong academic foundation, he embarked on an extensive research and teaching career across several leading institutions globally.Mr. Liu’s professional path includes serving as an Environmental Protection Engineer at the Songliao Water Conservancy Agency before moving into academic research and teaching. He held research positions at Zurich University Hospital in Switzerland, where he contributed significantly to studies in dermatology and regenerative medicine, followed by a research faculty position at the State University of New York at Buffalo in the Department of Biological and Chemical Engineering. Returning to China, he joined Jilin University, holding roles such as Vice Chair of the Department of Pathobiology, Chair of the Department of Toxicology, and later Professor at the School of Public Health, where he continues to teach and mentor future scientists.Throughout his career, Mr. Liu has contributed extensively to scientific literature with publications spanning diverse research areas. His works include studies on PBX1 attenuating MeHg-induced SH-SY5Y cell apoptosis, AT-PBX1 fusion protein alleviating LPS-induced acute lung injury, and viral hijacking of host DDX60 promoting Crimean-Congo hemorrhagic fever virus replication. He has explored type 3 diabetes and metabolic reprogramming of brain neurons, neurotoxic β-amyloid oligomers causing mitochondrial dysfunction in neurons, and research on the development and regeneration of hair follicles. His studies have also examined circadian clock regulation in hair follicle cycles, the role of PBX1 in mammalian kidneys, oxidative stress modulation in mesenchymal stem cells, and CRISPR-Cas12a-based detection of monkeypox virus.

Profile: Orcid

Featured Publications

Chen, Z., Liu, X., Zuo, K., Xin, Y., & Liu, J. (2025). TAT-PBX1 fusion protein alleviates LPS-induced acute lung injury via AMPK-TFAM signaling activation. Molecular Therapy.

Sui, Y., Marzi, A., Xu, Q., Liu, M., Liu, X., Liu, X., Wang, Y., Meng, X., Liu, Z., Li, Q., et al. (2025). Viral hijacking of host DDX60 promotes Crimean-Congo haemorrhagic fever virus replication via G-quadruplex unwinding. PLOS Pathogens, 21(6), e1013278.

Sui, Y., Liu, F., Zheng, S., Liu, X., Sun, P., Yao, C., Zhang, Y., Gao, H., Gao, X., & Liu, J. (2023). G-quadruplexes folding mediates downregulation of PBX1 expression in melanoma. Signal Transduction and Targeted Therapy, 8(1), 12.

Sui, Y., Xu, Q., Liu, M., Zuo, K., Liu, X., & Liu, J. (2022). CRISPR-Cas12a-based detection of monkeypox virus. Journal of Infection, 85(6), 702–769.

Ma, Y., Li, M., Liu, J., Pang, C., Zhang, J., Li, Y., & Fu, X. (2018). Location, isolation, and identification of mesenchymal stem cells from adult human sweat glands. Stem Cells International, Article ID 2090276.